DR. SOLIMAN ABDEL KADER FAKEEH HOSPITAL CO.DD

DR. SOLIMAN ABDEL KADER FAKEEH HOSPITAL CO.

63,9SARD
+0,5+0,79%
A partir de hoy a las 08:37 GMT
SAR
No hay operaciones
Ver en los supergráficos

Datos fundamentales de 4017

Estados financieros de DR. SOLIMAN ABDEL KADER FAKEEH HOSPITAL CO., incluidos ingresos, gastos y beneficios

Los ingresos totales de 4017 del último trimestre son 713.82 M SAR y esta cifra arroja una subida del 9.14% respecto al trimestre anterior. Los ingresos netos del Q3 24 son de 93.59 M SAR.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0,00‬
‪‪200,00 M‬‬
‪‪400,00 M‬‬
‪‪600,00 M‬‬
‪‪800,00 M‬‬
Ingresos totales
Beneficio bruto
Ingresos de explotación
Ingresos antes de impuestos
Ingresos netos
Divisa: SAR
Q3 '22
Sep 2022
Q4 '22
Dic 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q4 '23
Dic 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
TTM
Ingresos totalesCrecimiento interanual
‪‪540,37 M‬‬
‪‪529,41 M‬‬
‪‪545,67 M‬‬
‪‪589,29 M‬‬
+27,60%
‪‪662,32 M‬‬
+22,57%
‪‪680,33 M‬‬
+28,51%
‪‪654,04 M‬‬
+19,86%
‪‪713,82 M‬‬
+21,13%
‪‪2,71 B‬‬
‪‪−373,85 M‬‬
‪‪−385,01 M‬‬
‪‪−419,49 M‬‬
‪‪−413,29 M‬‬
‪‪−480,22 M‬‬
‪‪−491,75 M‬‬
‪‪−492,17 M‬‬
‪‪−530,00 M‬‬
‪‪−1,99 B‬‬
Beneficio brutoCrecimiento interanual
‪‪166,52 M‬‬
‪‪144,40 M‬‬
‪‪126,18 M‬‬
‪‪176,00 M‬‬
+32,98%
‪‪182,10 M‬‬
+9,36%
‪‪188,58 M‬‬
+30,60%
‪‪161,87 M‬‬
+28,29%
‪‪183,82 M‬‬
+4,44%
‪‪716,37 M‬‬
‪‪−68,92 M‬‬
‪‪−65,95 M‬‬
‪‪−67,59 M‬‬
‪‪−79,93 M‬‬
‪‪−102,37 M‬‬
‪‪−85,44 M‬‬
‪‪−90,50 M‬‬
‪‪−82,12 M‬‬
‪‪−360,43 M‬‬
Ingresos de explotaciónCrecimiento interanual
‪‪97,59 M‬‬
‪‪78,44 M‬‬
‪‪58,59 M‬‬
‪‪96,08 M‬‬
−1,16%
‪‪79,73 M‬‬
−18,30%
‪‪103,15 M‬‬
+31,49%
‪‪71,37 M‬‬
+21,81%
‪‪101,69 M‬‬
+5,85%
‪‪355,94 M‬‬
‪‪5,00 M‬‬
‪‪−12,93 M‬‬
‪‪−14,65 M‬‬
‪‪−15,78 M‬‬
‪‪−52,98 M‬‬
‪‪−35,43 M‬‬
‪‪−23,74 M‬‬
‪‪−939,89 K‬‬
‪‪−113,09 M‬‬
Ingresos antes de impuestosCrecimiento interanual
‪‪102,59 M‬‬
‪‪65,51 M‬‬
‪‪43,94 M‬‬
‪‪80,29 M‬‬
+0,81%
‪‪64,96 M‬‬
−36,68%
‪‪67,72 M‬‬
+3,37%
‪‪47,63 M‬‬
+8,39%
‪‪100,75 M‬‬
+25,48%
‪‪281,06 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−5,53 M‬‬
‪‪−4,99 M‬‬
‪‪−5,34 M‬‬
‪‪−10,50 M‬‬
‪‪−1,85 M‬‬
‪‪−7,02 M‬‬
‪‪−4,76 M‬‬
‪‪−9,03 M‬‬
‪‪−22,68 M‬‬
‪‪7,85 M‬‬
‪‪11,51 M‬‬
‪‪15,32 M‬‬
‪‪9,86 M‬‬
‪‪10,88 M‬‬
‪‪12,02 M‬‬
‪‪4,60 M‬‬
‪‪1,87 M‬‬
‪‪29,38 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪104,91 M‬‬
‪‪72,04 M‬‬
‪‪53,92 M‬‬
‪‪79,65 M‬‬
‪‪73,99 M‬‬
‪‪72,72 M‬‬
‪‪47,47 M‬‬
‪‪93,59 M‬‬
‪‪287,77 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Ingresos netosCrecimiento interanual
‪‪104,91 M‬‬
‪‪72,04 M‬‬
‪‪53,92 M‬‬
‪‪79,65 M‬‬
+14,64%
‪‪73,99 M‬‬
−29,47%
‪‪72,72 M‬‬
+0,95%
‪‪47,47 M‬‬
−11,96%
‪‪93,59 M‬‬
+17,50%
‪‪287,77 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪104,91 M‬‬
‪‪72,04 M‬‬
‪‪53,92 M‬‬
‪‪79,65 M‬‬
‪‪73,99 M‬‬
‪‪72,72 M‬‬
‪‪47,47 M‬‬
‪‪93,59 M‬‬
‪‪287,77 M‬‬
‪0,45‬
‪0,31‬
‪0,23‬
‪0,34‬
+14,62%
‪0,32‬
−29,48%
‪0,31‬
+0,97%
‪0,23‬
0,00%
‪0,44‬
+28,05%
‪1,30‬
‪0,45‬
‪0,31‬
‪0,23‬
‪0,34‬
+14,62%
‪0,32‬
−29,48%
‪0,31‬
+0,97%
‪0,23‬
0,00%
‪0,44‬
+28,05%
‪1,30‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪204,29 M‬‬
‪‪212,92 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪232,00 M‬‬
‪‪204,29 M‬‬
‪‪212,92 M‬‬
EBITDACrecimiento interanual
‪‪136,93 M‬‬
‪‪112,90 M‬‬
‪‪100,57 M‬‬
‪‪134,78 M‬‬
‪‪119,55 M‬‬
−12,69%
‪‪140,63 M‬‬
+24,56%
‪‪110,32 M‬‬
+9,70%
‪‪142,45 M‬‬
+5,69%
‪‪512,95 M‬‬
EBITCrecimiento interanual
‪‪97,59 M‬‬
‪‪78,44 M‬‬
‪‪58,59 M‬‬
‪‪96,08 M‬‬
−1,16%
‪‪79,73 M‬‬
−18,30%
‪‪103,15 M‬‬
+31,49%
‪‪71,37 M‬‬
+21,81%
‪‪101,69 M‬‬
+5,85%
‪‪355,94 M‬‬
‪‪−442,78 M‬‬
‪‪−450,96 M‬‬
‪‪−487,08 M‬‬
‪‪−493,22 M‬‬
‪‪−582,59 M‬‬
‪‪−577,19 M‬‬
‪‪−582,67 M‬‬
‪‪−612,13 M‬‬
‪‪−2,35 B‬‬